ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and currently lacks any effective targeted therapy. Since epigenetic alterations are a common event in TNBC, DNA methylation profiling can be useful for identifying potential biomarkers and therapeutic targets. Here, g...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendaza, Saioa, Ulazia-Garmendia, Ane, Monreal-Santesteban, Iñaki, Córdoba, Alicia, de Azúa, Yerani Ruiz, Aguiar, Begoña, Beloqui, Raquel, Armendáriz, Pedro, Arriola, Marta, Martín-Sánchez, Esperanza, Guerrero-Setas, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036924/
https://www.ncbi.nlm.nih.gov/pubmed/32019179
http://dx.doi.org/10.3390/ijms21030903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036924/
https://www.ncbi.nlm.nih.gov/pubmed/32019179
http://dx.doi.org/10.3390/ijms21030903

Ejemplares similares